Literature DB >> 21351730

Mutational analysis reveals a single binding interface between RhoA and its effector, PRK1.

Catherine L Hutchinson1, Peter N Lowe, Stephen H McLaughlin, Helen R Mott, Darerca Owen.   

Abstract

Protein kinase C-related kinases (PRKs) are serine/threonine kinases that are members of the protein kinase C superfamily and can be activated by binding to members of the Rho family of small G proteins via a Rho binding motif known as an HR1 domain. The PRKs contain three tandem HR1 domains at their N-termini. The structure of the HR1a domain from PRK1 in complex with RhoA [Maesaki, R., et al. (1999) Mol. Cell 4, 793-803] identified two potential contact interfaces between the G protein and the HR1a domain. In this work, we have used an alanine scanning mutagenesis approach to identify whether both contact sites are used when the two proteins interact in solution and also whether HR1b, the second HR1 domain from PRK1, plays a role in binding to RhoA. The mutagenesis identified just one contact site as being relevant for binding of RhoA and HR1a in solution, and the HR1b domain was found not to contribute to RhoA binding. The folded state and thermal stability of the HR1a and HR1b domains were also investigated. HR1b was found to be more thermally stable than HR1a, and it is hypothesized that the differences in the biophysical properties of these two domains govern their interaction with small G proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21351730     DOI: 10.1021/bi200039u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells.

Authors:  Hong Wang; Mohanad H Nada; Yoshimasa Tanaka; Shun Sakuraba; Craig T Morita
Journal:  J Immunol       Date:  2019-06-21       Impact factor: 5.422

2.  Modified SH2 domain to phototrap and identify phosphotyrosine proteins from subcellular sites within cells.

Authors:  Akiyoshi Uezu; Hirokazu Okada; Hideji Murakoshi; Cosmo D del Vescovo; Ryohei Yasuda; Dario Diviani; Scott H Soderling
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

3.  A Salmonella typhimurium-translocated glycerophospholipid:cholesterol acyltransferase promotes virulence by binding to the RhoA protein switch regions.

Authors:  Doris L LaRock; Peter S Brzovic; Itay Levin; Marie-Pierre Blanc; Samuel I Miller
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

4.  Protein docking prediction using predicted protein-protein interface.

Authors:  Bin Li; Daisuke Kihara
Journal:  BMC Bioinformatics       Date:  2012-01-10       Impact factor: 3.169

5.  1H, 15N and 13C resonance assignments of the HR1c domain of PRK1, a protein kinase C-related kinase.

Authors:  Georgios Sophocleous; George Wood; Darerca Owen; Helen R Mott
Journal:  Biomol NMR Assign       Date:  2020-06-04       Impact factor: 0.746

Review 6.  The structure and function of protein kinase C-related kinases (PRKs).

Authors:  Georgios Sophocleous; Darerca Owen; Helen R Mott
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

Review 7.  Lysophospholipid receptor activation of RhoA and lipid signaling pathways.

Authors:  Sunny Yang Xiang; Stephanie S Dusaban; Joan Heller Brown
Journal:  Biochim Biophys Acta       Date:  2012-09-15

8.  Investigation of the Interaction between Cdc42 and Its Effector TOCA1: HANDOVER OF Cdc42 TO THE ACTIN REGULATOR N-WASP IS FACILITATED BY DIFFERENTIAL BINDING AFFINITIES.

Authors:  Joanna R Watson; Helen M Fox; Daniel Nietlispach; Jennifer L Gallop; Darerca Owen; Helen R Mott
Journal:  J Biol Chem       Date:  2016-04-22       Impact factor: 5.157

9.  Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases.

Authors:  Catherine A Hurd; Paul Brear; Jefferson Revell; Sarah Ross; Helen R Mott; Darerca Owen
Journal:  J Biol Chem       Date:  2020-11-23       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.